IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v631y2024i8019d10.1038_s41586-024-07659-8.html
   My bibliography  Save this article

Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

Author

Listed:
  • Laura Riva

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

  • Shuofeng Yuan

    (The University of Hong Kong, Hong Kong Special Administrative Region
    The University of Hong Kong, Hong Kong Special Administrative Region
    The University of Hong Kong, Hong Kong Special Administrative Region)

  • Xin Yin

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

  • Laura Martin-Sancho

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

  • Naoko Matsunaga

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

  • Lars Pache

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

  • Sebastian Burgstaller-Muehlbacher

    (University of Vienna and Medical University of Vienna)

  • Paul D. Jesus

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

  • Peter Teriete

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

  • Mitchell V. Hull

    (Calibr at Scripps Research)

  • Max W. Chang

    (University of California, San Diego)

  • Jasper Fuk-Woo Chan

    (The University of Hong Kong, Hong Kong Special Administrative Region
    The University of Hong Kong, Hong Kong Special Administrative Region
    The University of Hong Kong, Hong Kong Special Administrative Region)

  • Jianli Cao

    (The University of Hong Kong, Hong Kong Special Administrative Region
    The University of Hong Kong, Hong Kong Special Administrative Region
    The University of Hong Kong, Hong Kong Special Administrative Region)

  • Vincent Kwok-Man Poon

    (The University of Hong Kong, Hong Kong Special Administrative Region
    The University of Hong Kong, Hong Kong Special Administrative Region
    The University of Hong Kong, Hong Kong Special Administrative Region)

  • Kristina M. Herbert

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

  • Kuoyuan Cheng

    (National Cancer Institute, National Institute of Health
    University of Maryland)

  • Tu-Trinh H. Nguyen

    (Calibr at Scripps Research)

  • Andrey Rubanov

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

  • Yuan Pu

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

  • Courtney Nguyen

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

  • Angela Choi

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Raveen Rathnasinghe

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Michael Schotsaert

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Lisa Miorin

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Marion Dejosez

    (Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai)

  • Thomas P. Zwaka

    (Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai)

  • Ko-Yung Sit

    (The University of Hong Kong, Hong Kong Special Administrative Region)

  • Luis Martinez-Sobrido

    (Texas Biomedical Research Institute)

  • Wen-Chun Liu

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Kris M. White

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Mackenzie E. Chapman

    (Purdue University)

  • Emma K. Lendy

    (Purdue University)

  • Richard J. Glynne

    (Inception Therapeutics)

  • Randy Albrecht

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Eytan Ruppin

    (National Cancer Institute, National Institute of Health)

  • Andrew D. Mesecar

    (Purdue University
    Purdue University)

  • Jeffrey R. Johnson

    (Icahn School of Medicine at Mount Sinai)

  • Christopher Benner

    (University of California, San Diego)

  • Ren Sun

    (University of California)

  • Peter G. Schultz

    (Calibr at Scripps Research)

  • Andrew I. Su

    (The Scripps Research Institute)

  • Adolfo García-Sastre

    (Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai)

  • Arnab K. Chatterjee

    (Calibr at Scripps Research)

  • Kwok-Yung Yuen

    (The University of Hong Kong, Hong Kong Special Administrative Region
    The University of Hong Kong, Hong Kong Special Administrative Region
    The University of Hong Kong, Hong Kong Special Administrative Region)

  • Sumit K. Chanda

    (Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute)

Abstract

No abstract is available for this item.

Suggested Citation

  • Laura Riva & Shuofeng Yuan & Xin Yin & Laura Martin-Sancho & Naoko Matsunaga & Lars Pache & Sebastian Burgstaller-Muehlbacher & Paul D. Jesus & Peter Teriete & Mitchell V. Hull & Max W. Chang & Jasper, 2024. "Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing," Nature, Nature, vol. 631(8019), pages 3-3, July.
  • Handle: RePEc:nat:nature:v:631:y:2024:i:8019:d:10.1038_s41586-024-07659-8
    DOI: 10.1038/s41586-024-07659-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-024-07659-8
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/s41586-024-07659-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:631:y:2024:i:8019:d:10.1038_s41586-024-07659-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.